- Home
- EVGOW vs XGN Comparison
EVGOW vs XGN Comparison
Compare EVGOW & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVGOW
- XGN
- Stock Information
- Founded
- EVGOW 2010
- XGN 2002
- Country
- EVGOW United States
- XGN United States
- Employees
- EVGOW 331
- XGN N/A
- Industry
- EVGOW Other Specialty Stores
- XGN Medical Specialities
- Sector
- EVGOW Consumer Discretionary
- XGN Health Care
- Exchange
- EVGOW Nasdaq
- XGN Nasdaq
- Market Cap
- EVGOW N/A
- XGN 138.3M
- IPO Year
- EVGOW N/A
- XGN 2019
- Fundamental
- Price
- EVGOW $0.20
- XGN $6.98
- Analyst Decision
- EVGOW
- XGN Strong Buy
- Analyst Count
- EVGOW 0
- XGN 2
- Target Price
- EVGOW N/A
- XGN $7.50
- AVG Volume (30 Days)
- EVGOW 74.7K
- XGN 248.8K
- Earning Date
- EVGOW 03-07-2025
- XGN 08-04-2025
- Dividend Yield
- EVGOW N/A
- XGN N/A
- EPS Growth
- EVGOW N/A
- XGN N/A
- EPS
- EVGOW N/A
- XGN N/A
- Revenue
- EVGOW $239,306,000.00
- XGN $56,724,000.00
- Revenue This Year
- EVGOW N/A
- XGN $18.92
- Revenue Next Year
- EVGOW N/A
- XGN $14.78
- P/E Ratio
- EVGOW N/A
- XGN N/A
- Revenue Growth
- EVGOW 73.08
- XGN 1.78
- 52 Week Low
- EVGOW $0.12
- XGN $1.78
- 52 Week High
- EVGOW $1.99
- XGN $7.95
- Technical
- Relative Strength Index (RSI)
- EVGOW 40.24
- XGN 52.18
- Support Level
- EVGOW $0.19
- XGN $6.82
- Resistance Level
- EVGOW $0.22
- XGN $7.15
- Average True Range (ATR)
- EVGOW 0.02
- XGN 0.36
- MACD
- EVGOW -0.00
- XGN -0.06
- Stochastic Oscillator
- EVGOW 37.38
- XGN 37.07
About EVGOW EVgo Inc.
EVgo owns and operates a public direct current fast-charging network in the US. Its network of charging stations provides electric vehicle charging infrastructure to consumers and businesses. The network is capable of charging all EV models and meets all charging standards currently available in the US. EVgo partners with national and regional chains of grocery stores, automotive original equipment manufacturers, hotels, shopping centers, gas stations, parking lot operators, local governments, and independent property owners to locate and deploy its EV charging infrastructure.
About XGN Exagen Inc.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.